|
|
Neurocrine Biosciences, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Neurocrine Biosciences Announces Positive Top-Line Data from Phase 3 Study...The market loves it and, as I recall, CAH was the key entry vehicle to the European market. Much to like . . . for a change. |
||||||||||||
|
|
return to message board, top of board |
